Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort
Objective Fatty liver disease (FLD), a global epidemic, is also a predictor of cardiometabolic disease (CMD) (type 2 diabetes or cardiovascular disease). Our objective was to examine whether progressive FLD, as assessed by fatty liver index (FLI), predicts increasing future CMD risk compared with re...
Saved in:
| Main Authors: | Tomi-Pekka Tuomainen, Jussi Pihlajamäki, Olubunmi O. Olubamwo, Jyrki K. Virtanen, Pekka Mantyselka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/9/e031420.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.
by: Sari Voutilainen, et al.
Published: (2007-01-01) -
Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents
by: Yoowon Kwon, et al.
Published: (2024-11-01) -
Participatory care plan for primary care patients with long-term diseases: results after a 36-month follow-up of a randomized controlled trial
by: Nina Tusa, et al.
Published: (2025-04-01) -
Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study
by: Tomi-Pekka Tuomainen, et al.
Published: (2015-01-01) -
Association between metabolic-associated fatty liver disease and risk of cardiometabolic multimorbidity: a disease trajectory analysis in UK Biobank
by: Yaqian Gao, et al.
Published: (2025-06-01)